Repligen Corporation is a life sciences tools and technology company that develops and markets highly innovative bioprocessing solutions and systems. Our products enable efficiencies in the process of manufacturing a wide range of biological drugs, including: monoclonal antibodies; recombinant proteins; cell and gene therapies; and vaccines. We are inspiring advances in bioprocessing for the customers we serve around the globe; primarily biopharmaceutical companies and contract development and manufacturing organizations (CDMOs).
The XCell® ATF System from Repligen is an innovative technology that consists of a controller and a cell retention device that enables the intensified cell culture to exponentially boost productivity in upstream bioprocessing. Upstream process intensification ... Continued